Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

For diagnosis 1 year after sample collection, the test detected mutations in 90% of patients.
What if we could predict if a patient's lung cancer would recur using a simple blood test?
There are currently a large number of ongoing trials examining immunotherapies for bladder, kidney, prostate, and renal cancers.